Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled, page-6

We expect to complete trial enrolment and provide a trial read out in Q4 2022.

Mmmmm..well, if I'm not mistaken, Q4 2022 has already passed for FY21/22 which means they must be referring to the 4th Quarter of FY 2022/23 ...somewhere between April and June next year.
Fantastic, can't wait !

Then it'll take a couple of years at least for data collection and comparison with the BigPharma drug.
After that, IF it were to be successful, FDA approval time etc...

The market has been open for an hour at this point - not a single trade.
Exciting times eh..